Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Development of the ThyCAT: A clinically useful computerized adaptive test to assess quality of life in thyroid cancer survivors.

Aschebrook-Kilfoy B, Ferguson BA, Angelos P, Kaplan EL, Grogan RH, Gibbons RD.

Surgery. 2018 Jan;163(1):137-142. doi: 10.1016/j.surg.2017.09.009. Epub 2017 Nov 8.

PMID:
29128190
2.

Novel EPHB4 Receptor Tyrosine Kinase Mutations and Kinomic Pathway Analysis in Lung Cancer.

Ferguson BD, Tan YH, Kanteti RS, Liu R, Gayed MJ, Vokes EE, Ferguson MK, Iafrate AJ, Gill PS, Salgia R.

Sci Rep. 2015 Jun 15;5:10641. doi: 10.1038/srep10641.

3.

Expression of the EPHB4 receptor tyrosine kinase in head and neck and renal malignancies--implications for solid tumors and potential for therapeutic inhibition.

Ferguson BD, Tretiakova MS, Lingen MW, Gill PS, Salgia R.

Growth Factors. 2014 Dec;32(6):202-6. doi: 10.3109/08977194.2014.980904. Epub 2014 Nov 13.

4.

Podcasting as a novel way to communicate with medical school applicants.

Ferguson BD, Bister MK, Krapec JN.

Perspect Med Educ. 2014 Sep;3(4):319-25. doi: 10.1007/s40037-014-0123-2.

5.

The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target.

Ferguson BD, Liu R, Rolle CE, Tan YH, Krasnoperov V, Kanteti R, Tretiakova MS, Cervantes GM, Hasina R, Hseu RD, Iafrate AJ, Karrison T, Ferguson MK, Husain AN, Faoro L, Vokes EE, Gill PS, Salgia R.

PLoS One. 2013 Jul 2;8(7):e67668. doi: 10.1371/journal.pone.0067668. Print 2013.

6.

EphB4 as a therapeutic target in mesothelioma.

Liu R, Ferguson BD, Zhou Y, Naga K, Salgia R, Gill PS, Krasnoperov V.

BMC Cancer. 2013 May 30;13:269. doi: 10.1186/1471-2407-13-269.

7.

Critical role for the receptor tyrosine kinase EPHB4 in esophageal cancers.

Hasina R, Mollberg N, Kawada I, Mutreja K, Kanade G, Yala S, Surati M, Liu R, Li X, Zhou Y, Ferguson BD, Nallasura V, Cohen KS, Hyjek E, Mueller J, Kanteti R, El Hashani E, Kane D, Shimada Y, Lingen MW, Husain AN, Posner MC, Waxman I, Villaflor VM, Ferguson MK, Varticovski L, Vokes EE, Gill P, Salgia R.

Cancer Res. 2013 Jan 1;73(1):184-94. doi: 10.1158/0008-5472.CAN-12-0915. Epub 2012 Oct 24. Erratum in: Cancer Res. 2013 Jul 15;73(14):4594.

8.

Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database.

Surati M, Robinson M, Nandi S, Faoro L, Demchuk C, Rolle CE, Kanteti R, Ferguson BD, Hasina R, Gangadhar TC, Salama AK, Arif Q, Kirchner C, Mendonca E, Campbell N, Limvorasak S, Villaflor V, Hensing TA, Krausz T, Vokes EE, Husain AN, Ferguson MK, Karrison TG, Salgia R.

J Clin Bioinforma. 2011 Feb 28;1(8):1-11. doi: 10.1186/2043-9113-1-8.

9.

Generation of comprehensive thoracic oncology database--tool for translational research.

Surati M, Robinson M, Nandi S, Faoro L, Demchuk C, Kanteti R, Ferguson B, Gangadhar T, Hensing T, Hasina R, Husain A, Ferguson M, Karrison T, Salgia R.

J Vis Exp. 2011 Jan 22;(47). pii: 2414. doi: 10.3791/2414.

10.

EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation.

Faoro L, Singleton PA, Cervantes GM, Lennon FE, Choong NW, Kanteti R, Ferguson BD, Husain AN, Tretiakova MS, Ramnath N, Vokes EE, Salgia R.

J Biol Chem. 2010 Jun 11;285(24):18575-85. doi: 10.1074/jbc.M109.075085. Epub 2010 Apr 1.

11.

MET/PKCbeta expression correlate with metastasis and inhibition is synergistic in lung cancer.

Faoro L, Cervantes GM, Ferguson BD, Seiwert TY, Yala S, Vigneswaran WT, Westerhoff M, Tretiakova MS, Ferguson MK, Moura GL, Husain AN, Vokes EE, Salgia R.

J Carcinog. 2009;8:15. doi: 10.4103/1477-3163.57857.

Supplemental Content

Loading ...
Support Center